AI-Driven Drug Discovery for Rare Diseases
- 17 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (5) , 2214-2231
Abstract
Rare diseases (RDs), affecting 300 million people globally, present a daunting public health challenge characterized by complexity, limited treatment options, and diagnostic hurdles. Despite legislative efforts, such as the 1983 US Orphan Drug Act, more than 90% of RDs lack effective therapies. Traditional drug discovery models, marked by lengthy development cycles and high failure rates, struggle to meet the unique demands of RDs, often yielding poor returns on investment. However, the advent of artificial intelligence (AI), encompassing machine learning (ML) and deep learning (DL), offers groundbreaking solutions. This review explores AI's potential to revolutionize drug discovery for RDs by overcoming these challenges. It discusses AI-driven advancements, such as drug repurposing, biomarker discovery, personalized medicine, genetics, clinical trial optimization, corporate innovations, and novel drug target identification. By synthesizing current knowledge and recent breakthroughs, this review provides crucial insights into how AI can accelerate therapeutic development for RDs, ultimately improving patient outcomes. This comprehensive analysis fills a critical gap in the literature, enhancing understanding of AI's pivotal role in transforming RD research and guiding future research and development efforts in this vital area of medicine.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (2022P5LPHS)
This publication has 97 references indexed in Scilit:
- DrugFormer: Graph‐Enhanced Language Model to Predict Drug SensitivityAdvanced Science, 2024
- A generic approach for reproducible model distillationMachine Learning, 2024
- Unlocking the Potential of Generative Artificial Intelligence in Drug Discovery2024
- Explainable AI in drug discovery: self-interpretable graph neural network for molecular property prediction using concept whiteningMachine Learning, 2023
- Artificial intelligence revolutionizing drug development: Exploring opportunities and challengesDrug Development Research, 2023
- Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins SyndromePharmaceutical Research, 2019
- What Precision Medicine Can Learn from Rare Genetic Disease Research and TranslationAMA Journal of Ethics, 2018
- Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence PlatformAdvanced Therapeutics, 2018
- Drug discovery and development for rare genetic disordersAmerican Journal of Medical Genetics Part A, 2017
- The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicineHuman Genetics, 2013